Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools. While the traditional staging systems, such as the TNM classification, focus on anatomical factors, they fall short in providing a comprehensive prognosis. The Tianjin Grading System addresses this gap by integrating anatomical, biological, and patient condition factors.
Continue Reading this article here
